F&FFinancial Insights

Financial Metrics

AVTR Avantor, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 23 | A: 9

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2018-06-30 1477900000.0 USD 10-Q 2019-08-06
Quarterly 2018-09-30 1494200000.0 +1.1% USD 10-Q 2019-11-05
Quarterly 2019-03-31 1480100000.0 -0.9% USD 10-Q 2020-04-29
Quarterly 2019-06-30 1532400000.0 +3.5% USD 10-Q 2020-07-29
Quarterly 2019-09-30 1503800000.0 -1.9% USD 10-Q 2020-10-27
Quarterly 2020-03-31 1519000000.0 +1.0% USD 10-Q 2021-04-28
Quarterly 2020-06-30 1478700000.0 -2.7% USD 10-Q 2021-07-30
Quarterly 2020-09-30 1605000000.0 +8.5% USD 10-Q 2021-10-29
Quarterly 2021-03-31 1785600000.0 +11.3% USD 10-Q 2022-04-29
Quarterly 2021-06-30 1858600000.0 +4.1% USD 10-Q 2022-07-29
Quarterly 2021-09-30 1834300000.0 -1.3% USD 10-Q 2022-10-28
Quarterly 2022-03-31 1950400000.0 +6.3% USD 10-Q 2023-04-28
Quarterly 2022-06-30 1910500000.0 -2.0% USD 10-Q 2023-07-28
Quarterly 2022-09-30 1856500000.0 -2.8% USD 10-Q 2023-10-27
Quarterly 2023-03-31 1780300000.0 -4.1% USD 10-Q 2024-04-26
Quarterly 2023-06-30 1743900000.0 -2.0% USD 10-Q 2024-07-26
Quarterly 2023-09-30 1720200000.0 -1.4% USD 10-Q 2024-10-25
Quarterly 2024-03-31 1679800000.0 -2.3% USD 10-Q 2025-04-25
Quarterly 2024-06-30 1702800000.0 +1.4% USD 10-Q 2025-08-01
Quarterly 2024-09-30 1714400000.0 +0.7% USD 10-Q 2025-10-29
Quarterly 2025-03-31 1581400000.0 -7.8% USD 10-Q 2025-04-25
Quarterly 2025-06-30 1683400000.0 +6.4% USD 10-Q 2025-08-01
Quarterly 2025-09-30 1623800000.0 -3.5% USD 10-Q 2025-10-29
Annual 2017-12-31 1247400000.0 USD 10-K 2020-02-14
Annual 2018-12-31 5864300000.0 +370.1% USD 10-K 2021-02-16
Annual 2019-12-31 6040300000.0 +3.0% USD 10-K 2022-02-11
Annual 2020-12-31 6393600000.0 +5.8% USD 10-K 2023-02-14
Annual 2021-12-31 7386100000.0 +15.5% USD 10-K 2024-02-14
Annual 2022-12-31 7512400000.0 +1.7% USD 10-K 2025-02-07
Annual 2023-12-31 6967200000.0 -7.3% USD 10-K 2026-02-11
Annual 2024-12-31 6783600000.0 -2.6% USD 10-K 2026-02-11
Annual 2025-12-31 6552200000.0 -3.4% USD 10-K 2026-02-11

Gross Profit

Q: 23 | A: 9

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2018-06-30 468000000.0 USD 10-Q 2019-08-06
Quarterly 2018-09-30 478700000.0 +2.3% USD 10-Q 2019-11-05
Quarterly 2019-03-31 475200000.0 -0.7% USD 10-Q 2020-04-29
Quarterly 2019-06-30 491100000.0 +3.3% USD 10-Q 2020-07-29
Quarterly 2019-09-30 474000000.0 -3.5% USD 10-Q 2020-10-27
Quarterly 2020-03-31 501900000.0 +5.9% USD 10-Q 2021-04-28
Quarterly 2020-06-30 490600000.0 -2.3% USD 10-Q 2021-07-30
Quarterly 2020-09-30 506400000.0 +3.2% USD 10-Q 2021-10-29
Quarterly 2021-03-31 612800000.0 +21.0% USD 10-Q 2022-04-29
Quarterly 2021-06-30 626500000.0 +2.2% USD 10-Q 2022-07-29
Quarterly 2021-09-30 615900000.0 -1.7% USD 10-Q 2022-10-28
Quarterly 2022-03-31 689900000.0 +12.0% USD 10-Q 2023-04-28
Quarterly 2022-06-30 647700000.0 -6.1% USD 10-Q 2023-07-28
Quarterly 2022-09-30 650700000.0 +0.5% USD 10-Q 2023-10-27
Quarterly 2023-03-31 624800000.0 -4.0% USD 10-Q 2024-04-26
Quarterly 2023-06-30 590000000.0 -5.6% USD 10-Q 2024-07-26
Quarterly 2023-09-30 578600000.0 -1.9% USD 10-Q 2024-10-25
Quarterly 2024-03-31 570500000.0 -1.4% USD 10-Q 2025-04-25
Quarterly 2024-06-30 581500000.0 +1.9% USD 10-Q 2025-08-01
Quarterly 2024-09-30 564400000.0 -2.9% USD 10-Q 2025-10-29
Quarterly 2025-03-31 534900000.0 -5.2% USD 10-Q 2025-04-25
Quarterly 2025-06-30 554100000.0 +3.6% USD 10-Q 2025-08-01
Quarterly 2025-09-30 526500000.0 -5.0% USD 10-Q 2025-10-29
Annual 2017-12-31 432800000.0 USD 10-K 2020-02-14
Annual 2018-12-31 1819800000.0 +320.5% USD 10-K 2021-02-16
Annual 2019-12-31 1920700000.0 +5.5% USD 10-K 2022-02-11
Annual 2020-12-31 2080500000.0 +8.3% USD 10-K 2023-02-14
Annual 2021-12-31 2502700000.0 +20.3% USD 10-K 2024-02-14
Annual 2022-12-31 2602800000.0 +4.0% USD 10-K 2025-02-07
Annual 2023-12-31 2363800000.0 -9.2% USD 10-K 2026-02-11
Annual 2024-12-31 2279300000.0 -3.6% USD 10-K 2026-02-11
Annual 2025-12-31 2139400000.0 -6.1% USD 10-K 2026-02-11

Operating Income

Q: 23 | A: 9

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2018-06-30 94400000.0 USD 10-Q 2019-08-06
Quarterly 2018-09-30 132200000.0 +40.0% USD 10-Q 2019-11-05
Quarterly 2019-03-31 137600000.0 +4.1% USD 10-Q 2020-04-29
Quarterly 2019-06-30 119100000.0 -13.4% USD 10-Q 2020-07-29
Quarterly 2019-09-30 143200000.0 +20.2% USD 10-Q 2020-10-27
Quarterly 2020-03-31 158400000.0 +10.6% USD 10-Q 2021-04-28
Quarterly 2020-06-30 166600000.0 +5.2% USD 10-Q 2021-07-30
Quarterly 2020-09-30 177200000.0 +6.4% USD 10-Q 2021-10-29
Quarterly 2021-03-31 266300000.0 +50.3% USD 10-Q 2022-04-29
Quarterly 2021-06-30 254700000.0 -4.4% USD 10-Q 2022-07-29
Quarterly 2021-09-30 237200000.0 -6.9% USD 10-Q 2022-10-28
Quarterly 2022-03-31 307000000.0 +29.4% USD 10-Q 2023-04-28
Quarterly 2022-06-30 295600000.0 -3.7% USD 10-Q 2023-07-28
Quarterly 2022-09-30 275800000.0 -6.7% USD 10-Q 2023-10-27
Quarterly 2023-03-31 231200000.0 -16.2% USD 10-Q 2024-04-26
Quarterly 2023-06-30 71700000.0 -69.0% USD 10-Q 2024-07-26
Quarterly 2023-09-30 210200000.0 +193.2% USD 10-Q 2024-10-25
Quarterly 2024-03-31 146300000.0 -30.4% USD 10-Q 2025-04-25
Quarterly 2024-06-30 175800000.0 +20.2% USD 10-Q 2025-08-01
Quarterly 2024-09-30 124600000.0 -29.1% USD 10-Q 2025-10-29
Quarterly 2025-03-31 147400000.0 +18.3% USD 10-Q 2025-04-25
Quarterly 2025-06-30 128800000.0 -12.6% USD 10-Q 2025-08-01
Quarterly 2025-09-30 -648800000.0 -603.7% USD 10-Q 2025-10-29
Annual 2017-12-31 -210400000.0 USD 10-K 2020-02-14
Annual 2018-12-31 413500000.0 +296.5% USD 10-K 2021-02-16
Annual 2019-12-31 551800000.0 +33.4% USD 10-K 2022-02-11
Annual 2020-12-31 706800000.0 +28.1% USD 10-K 2023-02-14
Annual 2021-12-31 972200000.0 +37.5% USD 10-K 2024-02-14
Annual 2022-12-31 1130200000.0 +16.3% USD 10-K 2025-02-07
Annual 2023-12-31 696400000.0 -38.4% USD 10-K 2026-02-11
Annual 2024-12-31 1084800000.0 +55.8% USD 10-K 2026-02-11
Annual 2025-12-31 -246200000.0 -122.7% USD 10-K 2026-02-11

Net Income

Q: 23 | A: 9

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2018-06-30 -26900000.0 USD 10-Q 2019-08-06
Quarterly 2018-09-30 34500000.0 +228.3% USD 10-Q 2019-11-05
Quarterly 2019-03-31 -6200000.0 -118.0% USD 10-Q 2020-04-29
Quarterly 2019-06-30 -48700000.0 -685.5% USD 10-Q 2020-07-29
Quarterly 2019-09-30 22100000.0 +145.4% USD 10-Q 2020-10-27
Quarterly 2020-03-31 47000000.0 +112.7% USD 10-Q 2021-04-28
Quarterly 2020-06-30 60200000.0 +28.1% USD 10-Q 2021-07-30
Quarterly 2020-09-30 -42200000.0 -170.1% USD 10-Q 2021-10-29
Quarterly 2021-03-31 164000000.0 +488.6% USD 10-Q 2022-04-29
Quarterly 2021-06-30 157800000.0 -3.8% USD 10-Q 2022-07-29
Quarterly 2021-09-30 156800000.0 -0.6% USD 10-Q 2022-10-28
Quarterly 2022-03-31 190400000.0 +21.4% USD 10-Q 2023-04-28
Quarterly 2022-06-30 187400000.0 -1.6% USD 10-Q 2023-07-28
Quarterly 2022-09-30 167000000.0 -10.9% USD 10-Q 2023-10-27
Quarterly 2023-03-31 121500000.0 -27.2% USD 10-Q 2024-04-26
Quarterly 2023-06-30 -7300000.0 -106.0% USD 10-Q 2024-07-26
Quarterly 2023-09-30 108400000.0 +1584.9% USD 10-Q 2024-10-25
Quarterly 2024-03-31 60400000.0 -44.3% USD 10-Q 2025-04-25
Quarterly 2024-06-30 92900000.0 +53.8% USD 10-Q 2025-08-01
Quarterly 2024-09-30 57800000.0 -37.8% USD 10-Q 2025-10-29
Quarterly 2025-03-31 64500000.0 +11.6% USD 10-Q 2025-04-25
Quarterly 2025-06-30 64700000.0 +0.3% USD 10-Q 2025-08-01
Quarterly 2025-09-30 -711800000.0 -1200.2% USD 10-Q 2025-10-29
Annual 2017-12-31 -145300000.0 USD 10-K 2020-02-14
Annual 2018-12-31 -86900000.0 +40.2% USD 10-K 2021-02-16
Annual 2019-12-31 37800000.0 +143.5% USD 10-K 2022-02-11
Annual 2020-12-31 116600000.0 +208.5% USD 10-K 2023-02-14
Annual 2021-12-31 572600000.0 +391.1% USD 10-K 2024-02-14
Annual 2022-12-31 686500000.0 +19.9% USD 10-K 2025-02-07
Annual 2023-12-31 321100000.0 -53.2% USD 10-K 2026-02-11
Annual 2024-12-31 711500000.0 +121.6% USD 10-K 2026-02-11
Annual 2025-12-31 -530200000.0 -174.5% USD 10-K 2026-02-11

EPS Basic

Q: 21 | A: 8

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2019-03-31 -0.59 USD/shares 10-Q 2020-04-29
Quarterly 2019-06-30 -0.98 -66.1% USD/shares 10-Q 2020-07-29
Quarterly 2019-09-30 0.01 +101.0% USD/shares 10-Q 2020-10-27
Quarterly 2020-03-31 0.05 +400.0% USD/shares 10-Q 2021-04-28
Quarterly 2020-06-30 0.08 +60.0% USD/shares 10-Q 2021-07-30
Quarterly 2020-09-30 -0.1 -225.0% USD/shares 10-Q 2021-10-29
Quarterly 2021-03-31 0.25 +350.0% USD/shares 10-Q 2022-04-29
Quarterly 2021-06-30 0.24 -4.0% USD/shares 10-Q 2022-07-29
Quarterly 2021-09-30 0.24 +0.0% USD/shares 10-Q 2022-10-28
Quarterly 2022-03-31 0.29 +20.8% USD/shares 10-Q 2023-04-28
Quarterly 2022-06-30 0.28 -3.4% USD/shares 10-Q 2023-07-28
Quarterly 2022-09-30 0.25 -10.7% USD/shares 10-Q 2023-10-27
Quarterly 2023-03-31 0.18 -28.0% USD/shares 10-Q 2024-04-26
Quarterly 2023-06-30 -0.01 -105.6% USD/shares 10-Q 2024-07-26
Quarterly 2023-09-30 0.16 +1700.0% USD/shares 10-Q 2024-10-25
Quarterly 2024-03-31 0.09 -43.8% USD/shares 10-Q 2025-04-25
Quarterly 2024-06-30 0.14 +55.6% USD/shares 10-Q 2025-08-01
Quarterly 2024-09-30 0.08 -42.9% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 0.09 +12.5% USD/shares 10-Q 2025-04-25
Quarterly 2025-06-30 0.09 +0.0% USD/shares 10-Q 2025-08-01
Quarterly 2025-09-30 -1.04 -1255.6% USD/shares 10-Q 2025-10-29
Annual 2018-12-31 -2.69 USD/shares 10-K 2021-02-16
Annual 2019-12-31 -0.84 +68.8% USD/shares 10-K 2022-02-11
Annual 2020-12-31 0.09 +110.7% USD/shares 10-K 2023-02-14
Annual 2021-12-31 0.86 +855.6% USD/shares 10-K 2024-02-14
Annual 2022-12-31 1.02 +18.6% USD/shares 10-K 2025-02-07
Annual 2023-12-31 0.48 -52.9% USD/shares 10-K 2026-02-11
Annual 2024-12-31 1.05 +118.8% USD/shares 10-K 2026-02-11
Annual 2025-12-31 -0.78 -174.3% USD/shares 10-K 2026-02-11

EPS Diluted

Q: 21 | A: 8

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2019-03-31 -0.59 USD/shares 10-Q 2020-04-29
Quarterly 2019-06-30 -0.98 -66.1% USD/shares 10-Q 2020-07-29
Quarterly 2019-09-30 0.01 +101.0% USD/shares 10-Q 2020-10-27
Quarterly 2020-03-31 0.05 +400.0% USD/shares 10-Q 2021-04-28
Quarterly 2020-06-30 0.08 +60.0% USD/shares 10-Q 2021-07-30
Quarterly 2020-09-30 -0.1 -225.0% USD/shares 10-Q 2021-10-29
Quarterly 2021-03-31 0.25 +350.0% USD/shares 10-Q 2022-04-29
Quarterly 2021-06-30 0.24 -4.0% USD/shares 10-Q 2022-07-29
Quarterly 2021-09-30 0.24 +0.0% USD/shares 10-Q 2022-10-28
Quarterly 2022-03-31 0.28 +16.7% USD/shares 10-Q 2023-04-28
Quarterly 2022-06-30 0.28 +0.0% USD/shares 10-Q 2023-07-28
Quarterly 2022-09-30 0.25 -10.7% USD/shares 10-Q 2023-10-27
Quarterly 2023-03-31 0.18 -28.0% USD/shares 10-Q 2024-04-26
Quarterly 2023-06-30 -0.01 -105.6% USD/shares 10-Q 2024-07-26
Quarterly 2023-09-30 0.16 +1700.0% USD/shares 10-Q 2024-10-25
Quarterly 2024-03-31 0.09 -43.8% USD/shares 10-Q 2025-04-25
Quarterly 2024-06-30 0.14 +55.6% USD/shares 10-Q 2025-08-01
Quarterly 2024-09-30 0.08 -42.9% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 0.09 +12.5% USD/shares 10-Q 2025-04-25
Quarterly 2025-06-30 0.09 +0.0% USD/shares 10-Q 2025-08-01
Quarterly 2025-09-30 -1.04 -1255.6% USD/shares 10-Q 2025-10-29
Annual 2018-12-31 -2.69 USD/shares 10-K 2021-02-16
Annual 2019-12-31 -0.84 +68.8% USD/shares 10-K 2022-02-11
Annual 2020-12-31 0.09 +110.7% USD/shares 10-K 2023-02-14
Annual 2021-12-31 0.85 +844.4% USD/shares 10-K 2024-02-14
Annual 2022-12-31 1.01 +18.8% USD/shares 10-K 2025-02-07
Annual 2023-12-31 0.47 -53.5% USD/shares 10-K 2026-02-11
Annual 2024-12-31 1.04 +121.3% USD/shares 10-K 2026-02-11
Annual 2025-12-31 -0.78 -175.0% USD/shares 10-K 2026-02-11

8-K Material Event Details

67 filings · 163 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

335 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-03 Eck Steven W SVP & Chief Accounting Officer Equity grant / award
A
Common Stock 31,645 $0.00 $0 130,978
2026-03-10 MEHRA SANJEEV K Dir Open-market buy
P
Common Stock 125,000 $8.01 $1,001,250 475,000
2026-02-23 Sokenu Claudius EVP, Chief Legal & Compliance Other disposed transaction
F
Common Stock 2,376 $8.89 $21,123 252,429
2026-02-20 Hankamer Brittany EVP, Chief HR Officer Other disposed transaction
F
Common Stock 1,453 $9.03 $13,121 250,728
2026-02-19 Hankamer Brittany EVP, Chief HR Officer Equity grant / award
A · derivative
Stock Options (Right to Buy) 317,310 $0.00 $0 317,310
2026-02-19 Hankamer Brittany EVP, Chief HR Officer Equity grant / award
A
Common Stock 80,618 $0.00 $0 252,181
2026-02-12 SUMME GREGORY L Dir Open-market buy
P
Common Stock 100,000 $9.40 $940,000 400,000
2026-01-02 Dingemans Simon Dir Equity grant / award
A
Common Stock 6,225 $0.00 $0 6,225
2025-12-05 MEHRA SANJEEV K Dir Open-market buy
P
Common Stock 350,000 $11.09 $3,881,500 350,000
2025-12-05 MEHRA SANJEEV K Dir Equity grant / award
A
Common Stock 8,106 $0.00 $0 8,106
2025-11-17 Ligner Emmanuel President and CEO Open-market buy
P
Common Stock 87,500 $11.35 $993,125 283,424
2025-11-10 Blenn Mary EVP, Chief Operating Officer Equity grant / award
A · derivative
Stock Options (Right to Buy) 47,058 $0.00 $0 47,058
2025-11-10 Blenn Mary EVP, Chief Operating Officer Equity grant / award
A
Common Stock 17,391 $0.00 $0 17,391
2025-10-30 SUMME GREGORY L Dir Open-market buy
P
Common Stock 100,000 $11.25 $1,125,000 300,000
2025-10-03 LUCIER GREGORY T Dir Equity grant / award
A
Common Stock 8,736 $0.00 $0 8,736
2025-10-02 Gourdier Benoit EVP, Bioscience Production Other disposed transaction
F
Common Stock 1,264 $13.77 $17,405 235,684
2025-08-21 SUMME GREGORY L Dir Open-market buy
P
Common Stock 100,000 $12.56 $1,256,000 200,000
2025-08-18 Ligner Emmanuel President and CEO Equity grant / award
A · derivative
Stock Options (Right to Buy) 573,394 $0.00 $0 573,394
2025-08-18 Ligner Emmanuel President and CEO Equity grant / award
A
Common Stock 195,924 $0.00 $0 195,924
2025-08-14 Hankamer Brittany EVP, Chief HR Officer Other disposed transaction
F
Common Stock 181 $12.98 $2,349 171,563
2025-08-08 Couturier Christophe EVP, AMEA Equity grant / award
A
Common Stock 65,217 $0.00 $0 211,271
2025-08-05 Eck Steven W SVP & Chief Accounting Officer Open-market sell
S
Common Stock 3,476 $11.39 $39,592 55,068
2025-07-31 Eck Steven W SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 1,385 $13.44 $18,614 58,544
2025-07-24 Sokenu Claudius EVP, Chief Legal & Compliance Other disposed transaction
F
Common Stock 3,123 $14.01 $43,753 177,106
2025-06-21 Walker Corey President Laboratory Solutions Other disposed transaction
F
Common Stock 2,730 $13.57 $37,046 231,271
2025-05-23 SUMME GREGORY L Dir Open-market buy
P
Common Stock 30,000 $12.50 $375,000 100,000
2025-05-22 SUMME GREGORY L Dir Open-market buy
P
Common Stock 20,000 $12.65 $253,000 70,000
2025-05-21 Stubblefield Michael President & CEO Equity grant / award
G
Common Stock 76,000 $0.00 $0 545,500
2025-05-09 Walker Corey President Laboratory Solutions Equity grant / award
A
Common Stock 162,866 $0.00 $0 234,001
2025-05-08 Carethers John Dir Equity grant / award
A
Common Stock 17,100 $0.00 $0 45,858
2025-05-07 SUMME GREGORY L Dir Open-market buy
P
Common Stock 25,000 $12.00 $300,000 50,000
2025-04-29 Massaro Joseph R Dir Open-market buy
P
Common Stock 8,100 $12.30 $99,630 35,038
2025-04-28 SUMME GREGORY L Dir Open-market buy
P
Common Stock 25,000 $12.50 $312,500 25,000
2025-04-05 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 569 $15.13 $8,609 83,840
2025-02-27 Bramwell James EVP Sales, Customer Excellence Open-market sell
S
Common Stock 774 $17.00 $13,158 86,605
2025-02-26 Bramwell James EVP Sales, Customer Excellence Open-market sell
S
Common Stock 3,758 $17.53 $65,878 87,379
2025-02-25 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 556 $17.56 $9,763 84,409
2025-02-24 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 750 $17.47 $13,102 84,965
2025-02-23 Gourdier Benoit EVP, Bioscience Production Other disposed transaction
F
Common Stock 2,842 $17.30 $49,167 74,082
2025-02-23 Bramwell James EVP Sales, Customer Excellence Other disposed transaction
F
Common Stock 3,443 $17.30 $59,564 93,901
2025-02-20 Gourdier Benoit EVP, Bioscience Production Equity grant / award
A · derivative
Stock Options (Right to Buy) 86,565 $0.00 $0 86,565
2025-02-20 Gourdier Benoit EVP, Bioscience Production Equity grant / award
A
Common Stock 35,734 $0.00 $0 76,924
2024-11-04 Makin Louise Dir Equity grant / award
A
Common Stock 4,770 $0.00 $0 4,770
2024-10-02 Gourdier Benoit EVP, Bioscience Production Other disposed transaction
F
Common Stock 1,263 $25.54 $32,257 41,190
2024-09-05 Eck Steven W SVP & Chief Accounting Officer Open-market sell
S
Common Stock 3,525 $25.06 $88,336 29,544
2024-08-14 Hankamer Brittany EVP, Chief HR Officer Other disposed transaction
F
Common Stock 180 $25.07 $4,513 34,786
2024-07-31 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 100 $28.00 $2,800 73,930
2024-07-31 Eck Steven W SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 1,337 $26.75 $35,765 33,069
2024-07-30 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 10,000 $27.00 $270,000 74,030
2024-07-24 Sokenu Claudius EVP, Chief Legal & Compliance Other disposed transaction
F
Common Stock 3,122 $22.37 $69,839 38,958
2024-07-18 Sahin Kitty EVP, Strategy&Corp Development Other disposed transaction
F
Common Stock 3,931 $20.74 $81,529 42,274
2024-06-21 Walker Corey President Laboratory Solutions Equity grant / award
A · derivative
Stock Options (Right to Buy) 70,462 $0.00 $0 70,462
2024-06-21 Walker Corey President Laboratory Solutions Equity grant / award
A
Common Stock 28,254 $0.00 $0 28,254
2024-05-09 Murthy Mala Dir Equity grant / award
A
Common Stock 8,477 $0.00 $0 27,109
2024-04-16 Stone Randy Lee EVP, Laboratory Solutions Other disposed transaction
F
Common Stock 6,762 $24.60 $166,345 68,105
2024-04-05 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 569 $25.87 $14,720 83,320
2024-03-08 Eck Steven W SVP & Chief Accounting Officer Open-market sell
S
Common Stock 3,685 $25.63 $94,447 34,406
2024-02-29 Bramwell James EVP Sales, Customer Excellence Open-market sell
S
Common Stock 4,910 $24.52 $120,393 96,233
2024-02-25 Stubblefield Michael President & CEO Other disposed transaction
F
Common Stock 7,685 $24.35 $187,130 1,111,751
2024-02-24 Stubblefield Michael President & CEO Other disposed transaction
F
Common Stock 9,595 $24.35 $233,638 1,119,436
2024-02-24 Sahin Kitty EVP, Strategy&Corp Development Other disposed transaction
F
Common Stock 1,059 $24.35 $25,787 33,885
2024-02-23 Stubblefield Michael President & CEO Other disposed transaction
F
Common Stock 7,422 $24.35 $180,726 1,129,031
2024-02-23 Stubblefield Michael President & CEO Equity grant / award
A · derivative
Stock Options (Right to Buy) 263,558 $0.00 $0 263,558
2024-02-23 Stubblefield Michael President & CEO Equity grant / award
A
Common Stock 107,802 $0.00 $0 1,219,553
2024-02-22 Stubblefield Michael President & CEO Other disposed transaction
F
Common Stock 41,177 $24.59 $1,012,542 1,136,453
2024-02-22 Stubblefield Michael President & CEO Equity grant / award
A
Common Stock 99,075 $0.00 $0 1,177,630
2024-02-20 Hankamer Brittany EVP, Chief HR Officer Other disposed transaction
F
Common Stock 289 $24.05 $6,950 24,900
2023-12-31 Lewis Sheri EVP, Global Ops & Supply Chain Other disposed transaction
F
Common Stock 4,556 $22.83 $104,013 70,692
2023-10-02 Gourdier Benoit EVP, Biopharma Production Equity grant / award
A · derivative
Stock Options (Right to Buy) 39,281 $0.00 $0 39,281
2023-10-02 Gourdier Benoit EVP, Biopharma Production Equity grant / award
A
Common Stock 16,786 $0.00 $0 16,786
2023-09-07 Eck Steven W SVP & Chief Accounting Officer Open-market sell
S
Common Stock 7,577 $20.64 $156,389 28,187
2023-09-05 Hankamer Brittany EVP, Chief HR Officer Other disposed transaction
F
Common Stock 309 $21.70 $6,705 25,189
2023-08-25 Vanderhaegen Frederic EVP, Americas and Europe Open-market sell
S
Common Stock 25,000 $21.47 $536,750 160,735
2023-08-07 Jones R. Brent EVP, Chief Financial Officer Equity grant / award
A · derivative
Stock Options (Right to Buy) 295,559 $0.00 $0 295,559
2023-07-31 Eck Steven W SVP & Chief Accounting Officer Equity grant / award
A
Common Stock 14,584 $0.00 $0 35,764
2023-07-24 Sokenu Claudius EVP, Chief Legal & Compliance Equity grant / award
A · derivative
Stock Options (Right to Buy) 32,929 $0.00 $0 32,929
2023-07-24 Sokenu Claudius EVP, Chief Legal & Compliance Equity grant / award
A
Common Stock 24,627 $0.00 $0 24,627
2023-07-18 Sahin Kitty EVP, Strategy&Corp Development Other disposed transaction
F
Common Stock 3,931 $21.01 $82,590 34,944
2023-05-26 Stubblefield Michael President & CEO Equity grant / award
G
Common Stock 40,000 $0.00 $0 469,500
2023-05-17 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 15,706 $20.28 $318,518 82,944
2023-05-11 SEVERINO MICHAEL Dir Equity grant / award
A
Common Stock 9,808 $0.00 $0 34,974
2023-04-16 Stone Randy Lee EVP, Proprietary Products Equity grant / award
A · derivative
Stock Options (Right to Buy) 252,238 $0.00 $0 252,238
2023-04-16 Stone Randy Lee EVP, Proprietary Products Equity grant / award
A
Common Stock 48,332 $0.00 $0 48,332
2023-04-11 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 1,498 $21.18 $31,728 98,650
2023-04-05 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 569 $20.82 $11,847 100,148
2023-03-03 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 3,914 $25.00 $97,850 108,715
2023-02-28 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 2,324 $24.32 $56,520 100,717
2023-02-27 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 3,059 $25.00 $76,475 112,629
2023-02-25 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 2,040 $24.62 $50,225 115,688
2023-02-24 Brophy Gerard EVP, Biopharma Production Equity grant / award
A · derivative
Stock Options (Right to Buy) 49,215 $0.00 $0 49,215
2023-02-24 Brophy Gerard EVP, Biopharma Production Equity grant / award
A
Common Stock 20,308 $0.00 $0 117,728
2023-02-24 Sahin Kitty EVP, Strategy&Corp Development Equity grant / award
A · derivative
Stock Options (Right to Buy) 29,529 $0.00 $0 29,529
2023-02-24 Sahin Kitty EVP, Strategy&Corp Development Equity grant / award
A
Common Stock 12,185 $0.00 $0 38,875
2023-02-23 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 1,893 $24.59 $46,549 97,420
2023-02-20 Szlosek Thomas A EVP & CFO Other disposed transaction
F
Common Stock 4,253 $24.54 $104,369 90,872
2023-01-31 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 7,658 $23.90 $183,026 118,191
2023-01-31 Couturier Christophe EVP, AMEA Equity grant / award
A
Common Stock 26,818 $0.00 $0 125,849
2023-01-02 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 6,727 $21.09 $141,872 90,208
2022-12-31 Henson Meghan EVP, Chief HR Officer Other disposed transaction
F
Common Stock 1,790 $21.09 $37,751 29,615
2022-11-16 Szlosek Thomas A EVP & CFO Open-market buy
P
Common Stock 12,500 $20.71 $258,850 35,668
2022-05-23 Vanderhaegen Frederic EVP, Americas & Europe Open-market sell
S
Common Stock 39,000 $31.61 $1,232,790 126,764
2022-05-20 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 19,603 $31.27 $612,986 96,935
2022-05-17 Vanderhaegen Frederic EVP, Americas & Europe Other disposed transaction
F
Common Stock 2,210 $31.33 $69,239 165,764
2022-05-12 SEVERINO MICHAEL Dir Equity grant / award
A
Common Stock 6,693 $0.00 $0 25,166
2022-05-04 Stubblefield Michael President and CEO Equity grant / award
G
Common Stock 14,500 $0.00 $0 414,500
2022-04-05 Couturier Christophe EVP, AMEA Other disposed transaction
F
Common Stock 568 $31.62 $17,960 114,560
2022-04-01 Holt Matthew S. Dir Equity grant / award
A
Common Stock 1,215 $0.00 $0 1,215
2022-03-01 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 2,027 $34.47 $69,871 136,221
2022-02-25 Vanderhaegen Frederic EVP, Americas & Europe Other disposed transaction
F
Common Stock 216 $35.39 $7,644 167,974
2022-02-23 Vanderhaegen Frederic EVP, Americas & Europe Equity grant / award
A · derivative
Stock Options (Right to Buy) 43,708 $0.00 $0 43,708
2022-02-23 Vanderhaegen Frederic EVP, Americas & Europe Equity grant / award
A
Common Stock 15,110 $0.00 $0 168,190
2022-02-20 Miller Justin EVP & General Counsel Other disposed transaction
F
Common Stock 1,328 $34.00 $45,152 86,030
2022-01-13 Murray Mark Christopher EVP, Biomaterials & AT Other disposed transaction
F
Common Stock 918 $37.50 $34,425 18,680
2022-01-02 Wondrasch Michael EVP & CIO Other disposed transaction
F
Common Stock 9,517 $42.14 $401,046 104,312
2021-12-31 Henson Meghan EVP, Chief HR Officer Other disposed transaction
F
Common Stock 1,877 $42.14 $79,097 24,025
2021-12-27 Couturier Christophe EVP, AMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,184 $0.00 $0 96,901
2021-12-27 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 10,184 $41.63 $423,960 110,497
2021-12-27 Couturier Christophe EVP, AMEA Exercise / conversion
M
Common Stock 10,184 $23.21 $236,371 120,681
2021-12-22 Couturier Christophe EVP, AMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 28,125 $0.00 $0 107,085
2021-12-22 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 28,125 $41.53 $1,168,031 110,497
2021-12-22 Couturier Christophe EVP, AMEA Exercise / conversion
M
Common Stock 28,125 $23.21 $652,781 138,622
2021-12-21 Couturier Christophe EVP, AMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 38,309 $0.00 $0 96,901
2021-12-21 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 38,309 $41.00 $1,570,669 110,497
2021-12-21 Couturier Christophe EVP, AMEA Exercise / conversion
M
Common Stock 38,309 $23.21 $889,152 148,806
2021-12-09 Couturier Christophe EVP, AMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 7,859 $0.00 $0 41,058
2021-12-09 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 7,859 $40.24 $316,246 110,497
2021-12-09 Couturier Christophe EVP, AMEA Exercise / conversion
M
Common Stock 7,859 $17.67 $138,869 118,356
2021-12-08 Couturier Christophe EVP, AMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 5,828 $0.00 $0 48,917
2021-12-08 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 5,828 $40.00 $233,120 110,497
2021-12-08 Couturier Christophe EVP, AMEA Exercise / conversion
M
Common Stock 5,828 $17.67 $102,981 116,325
2021-12-01 GUPTA RAJIV Dir Open-market sell
S
Common Stock 100,000 $39.30 $3,930,000 879,347
2021-11-12 Vanderhaegen Frederic EVP, Europe Exercise / conversion
M · derivative
Stock Options (Right to Buy) 80,000 $0.00 $0 460,830
2021-11-12 Vanderhaegen Frederic EVP, Europe Open-market sell
S
Common Stock 80,000 $38.25 $3,060,000 154,495
2021-11-12 Vanderhaegen Frederic EVP, Europe Exercise / conversion
M
Common Stock 80,000 $23.20 $1,856,000 234,495
2021-11-11 Vanderhaegen Frederic EVP, Europe Open-market sell
S
Common Stock 60,804 $38.41 $2,335,482 154,495
2021-11-08 Massaro Joseph R Dir Equity grant / award
A
Common Stock 745 $0.00 $0 745
2021-11-01 GUPTA RAJIV Dir Open-market sell
S
Common Stock 100,000 $40.31 $4,031,000 979,347
2021-10-28 Murthy Mala Dir Equity grant / award
A
Common Stock 916 $0.00 $0 916
2021-10-01 GUPTA RAJIV Dir Open-market sell
S
Common Stock 100,000 $39.94 $3,994,000 1,079,347
2021-09-20 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 141,300 $42.37 $5,986,881 1,261,981
2021-09-01 GUPTA RAJIV Dir Open-market sell
S
Common Stock 100,000 $39.45 $3,945,000 1,179,347
2021-08-26 Eck Steven W SVP & Chief Accounting Officer Open-market sell
S
Common Stock 17,383 $40.08 $696,711 14,148
2021-08-20 GUPTA RAJIV Dir Open-market sell
S
Common Stock 100,000 $38.81 $3,881,000 1,279,347
2021-07-30 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M · derivative
Stock Options (Right to Buy) 81,125 $0.00 $0 81,125
2021-07-30 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 81,125 $37.24 $3,021,095 149,379
2021-07-30 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M
Common Stock 81,125 $23.20 $1,882,100 230,504
2021-07-20 Bramwell James EVP, Strategic Partners Open-market sell
S
Common Stock 6,112 $37.00 $226,144 79,899
2021-07-15 Carethers John Dir Equity grant / award
A
Common Stock 2,565 $0.00 $0 2,565
2021-07-12 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 300 $36.33 $10,900 557,656
2021-07-09 Bramwell James EVP, Strategic Partners Open-market sell
S
Common Stock 12,221 $35.64 $435,556 86,011
2021-07-09 Bramwell James EVP, Strategic Partners Open-market sell
S
Common Stock 6,110 $35.56 $217,272 98,232
2021-06-28 Couturier Christophe EVP, AMEA Open-market sell
S
Common Stock 28,096 $35.73 $1,003,870 110,077
2021-06-25 GUPTA RAJIV Dir Open-market sell
S
Common Stock 68,605 $35.32 $2,423,129 1,379,347
2021-06-10 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 42,512 $0.00 $0 0
2021-06-10 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 57,375 $32.48 $1,863,540 1,403,281
2021-06-10 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Common Stock 57,375 $0.00 $0 0
2021-06-10 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 42,512 $32.48 $1,380,790 1,403,281
2021-06-10 Stubblefield Michael President and CEO Exercise / conversion
M
Common Stock 42,512 $3.13 $133,063 1,445,793
2021-06-09 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 235,170 $0.00 $0 42,512
2021-06-09 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 235,170 $32.03 $7,532,495 1,403,281
2021-06-09 Stubblefield Michael President and CEO Exercise / conversion
M
Common Stock 235,170 $3.13 $736,082 1,638,451
2021-06-08 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 152,643 $0.00 $0 277,682
2021-06-08 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 152,643 $32.04 $4,890,682 1,403,281
2021-06-08 Stubblefield Michael President and CEO Exercise / conversion
M
Common Stock 152,643 $3.13 $477,773 1,555,924
2021-05-27 GUPTA RAJIV Dir Open-market sell
S
Common Stock 78,109 $31.94 $2,494,801 278,109
2021-05-27 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 100,000 $0.00 $0 347,181
2021-05-27 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 100,000 $31.99 $3,199,000 139,095
2021-05-27 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 100,000 $23.21 $2,321,000 239,095
2021-05-26 GUPTA RAJIV Dir Open-market sell
S
Common Stock 150,000 $31.89 $4,783,500 356,218
2021-05-24 GUPTA RAJIV Dir Open-market sell
S
Common Stock 157,571 $31.57 $4,974,516 506,218
2021-05-24 GUPTA RAJIV Dir Open-market sell
S
Common Stock 180,000 $31.74 $5,713,200 663,789
2021-05-21 Wondrasch Michael EVP & CIO Open-market sell
S
Common Stock 18,488 $31.41 $580,708 113,295
2021-05-20 Miller Justin EVP & General Counsel Open-market sell
S
Common Stock 18,488 $31.12 $575,347 86,536
2021-05-17 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 19,683 $30.90 $608,205 168,982
2021-05-14 Kang Lan Dir Equity grant / award
A
Common Stock 4,022 $0.00 $0 4,022
2021-05-11 Natauri Jo Dir Other acquired transaction
J
Common Stock, par value $0.01 per share 92,661 $30.86 $2,859,518 92,661
2021-05-11 Natauri Jo Dir Other disposed transaction
J
Common Stock, par value $0.01 per share 24,729,495 $30.86 $763,152,216 175,625
2021-05-11 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 2,626,771 $30.68 $80,589,334 24,807,518
2021-04-30 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 53,649 $0.00 $0 487,181
2021-04-30 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 53,649 $32.58 $1,747,884 155,888
2021-04-30 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 53,649 $23.21 $1,245,193 209,537
2021-04-12 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 100,160 $0.00 $0 0
2021-04-12 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 100,160 $32.37 $3,242,179 155,888
2021-04-12 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 100,160 $1.60 $160,256 256,048
2021-04-05 Couturier Christophe EVP, AMEA Equity grant / award
A
Common Stock 8,267 $0.00 $0 177,459
2021-03-09 Vanderhaegen Frederic EVP, Europe Open-market sell
S
Common Stock 10,000 $28.21 $282,100 243,669
2021-03-02 Wondrasch Michael EVP & CIO Open-market sell
S
Common Stock 3,036 $28.71 $87,164 145,438
2021-02-25 Eck Steven W SVP & Chief Accounting Officer Equity grant / award
A · derivative
Stock Options (Right to Buy) 19,906 $0.00 $0 19,906
2021-02-25 Eck Steven W SVP & Chief Accounting Officer Equity grant / award
A
Common Stock 6,151 $0.00 $0 32,084
2021-02-24 Eck Steven W SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 2,577 $27.94 $72,001 25,955
2021-02-24 Eck Steven W SVP & Chief Accounting Officer Exercise / conversion
M
Common Stock 8,550 $0.00 $0 28,532
2021-02-22 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M · derivative
Stock Options (Right to Buy) 19,769 $0.00 $0 59,306
2021-02-22 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 19,769 $28.62 $565,789 175,443
2021-02-22 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M
Common Stock 19,769 $17.67 $349,318 195,212
2021-02-22 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 3,072 $28.69 $88,136 175,443
2021-02-05 Wondrasch Michael EVP & CIO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 40,000 $0.00 $0 230,415
2021-02-05 Wondrasch Michael EVP & CIO Open-market sell
S
Common Stock 40,000 $29.77 $1,190,800 141,543
2021-02-05 Wondrasch Michael EVP & CIO Exercise / conversion
M
Common Stock 40,000 $23.20 $928,000 181,543
2021-02-05 Wondrasch Michael EVP & CIO Open-market sell
S
Common Stock 9,468 $29.77 $281,862 141,543
2021-01-13 Murray Mark Christopher EVP, Biomaterials & AT Other disposed transaction
F
Common Stock 918 $29.20 $26,806 11,458
2021-01-11 Bramwell James EVP, Strategic Partners Open-market sell
S
Common Stock 2,505 $30.00 $75,150 116,430
2021-01-06 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 11,509 $27.24 $313,505 178,515
2021-01-04 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M · derivative
Stock Options (Right to Buy) 59,418 $0.00 $0 118,835
2021-01-04 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 59,418 $27.84 $1,654,197 190,024
2021-01-04 Brophy Gerard EVP, Biopharma Production Exercise / conversion
M
Common Stock 59,418 $18.45 $1,096,262 249,442
2021-01-02 Brophy Gerard EVP, Biopharma Production Other disposed transaction
F
Common Stock 6,559 $28.15 $184,636 190,024
2020-12-31 Henson Meghan EVP, Chief HR Officer Equity grant / award
A · derivative
Stock Options (Right to Buy) 177,305 $0.00 $0 177,305
2020-12-31 Henson Meghan EVP, Chief HR Officer Equity grant / award
A
Common Stock 17,762 $0.00 $0 17,762
2020-12-21 Bramwell James EVP, Strategic Partners Open-market sell
S
Common Stock 10,020 $27.14 $271,943 117,768
2020-12-11 Stubblefield Michael President and CEO Equity grant / award
G
Common Stock 400,000 $0.00 $0 400,000
2020-12-07 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 201,369 $0.00 $0 0
2020-12-07 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 98,452 $27.45 $2,702,507 1,847,265
2020-12-07 Stubblefield Michael President and CEO Exercise / conversion
M
Common Stock 210,369 $1.60 $336,590 1,945,717
2020-12-04 Stubblefield Michael President and CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 880,601 $0.00 $0 201,369
2020-12-04 Stubblefield Michael President and CEO Open-market sell
S
Common Stock 412,188 $27.08 $11,162,051 1,735,348
2020-12-04 Stubblefield Michael President and CEO Exercise / conversion
M
Common Stock 880,601 $1.60 $1,408,962 2,147,536
2020-11-10 New Mountain Investments III, LLC 10% Open-market sell
S
Common Stock 36,016,093 $24.81 $893,490,837 28,000,000
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 50,000 $0.00 $0 100,160
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 35,000 $0.00 $0 150,160
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 18,440 $0.00 $0 0
2020-10-05 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 50,000 $23.34 $1,167,000 151,671
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 50,000 $1.60 $80,000 201,671
2020-10-05 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 35,000 $23.47 $821,450 151,671
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 35,000 $1.60 $56,000 186,671
2020-10-05 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 18,440 $23.53 $433,893 151,671
2020-10-05 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 18,440 $1.60 $29,504 170,111
2020-09-16 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 35,000 $0.00 $0 18,440
2020-09-16 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 35,000 $23.02 $805,700 151,671
2020-09-16 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 35,000 $1.60 $56,000 186,671
2020-09-08 Miller Justin EVP & General Counsel Open-market sell
S
Common Stock 22,887 $21.17 $484,518 113,507
2020-08-21-04:00 Natauri Jo Open-market sell
S
Common Stock, par value $0.01 per share 15,397,005 $19.51 $300,341,678 43,483,708
2020-08-19 GUPTA RAJIV Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 430,325 $0.00 $0 0
2020-08-19 GUPTA RAJIV Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 717,645 $0.00 $0 0
2020-08-19 GUPTA RAJIV Dir Equity grant / award
G
Common Stock 100,000 $0.00 $0 1,756,716
2020-08-19 GUPTA RAJIV Dir Exercise / conversion
M
Common Stock 1,147,970 $1.60 $1,836,752 1,856,716
2020-07-30 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 35,000 $0.00 $0 53,440
2020-07-30 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 35,000 $21.37 $747,950 151,671
2020-07-30 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 35,000 $1.60 $56,000 186,671
2020-07-01 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 62 $16.99 $1,053 58,861,148
2020-07-01 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 13,404 $17.09 $229,074 58,861,086
2020-07-01 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 2,006 $16.99 $34,082 58,874,490
2020-07-01 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 347 $16.99 $5,896 58,876,496
2020-07-01 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 436 $16.99 $7,408 58,876,149
2020-07-01 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 10,000 $17.00 $170,000 58,875,713
2020-07-01 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 646 $16.99 $10,976 58,885,713
2020-06-30 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 56 $17.16 $961 58,883,342
2020-06-30 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 1,103 $17.10 $18,861 58,883,286
2020-06-30 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 3,653 $17.10 $62,466 58,882,183
2020-06-30 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 400 $17.00 $6,800 58,885,836
2020-06-30 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 584 $17.10 $9,986 58,885,436
2020-06-30 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 400 $17.00 $6,800 58,884,852
2020-06-30 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 1,910 $17.10 $32,661 58,885,252
2020-06-26 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 20 $16.82 $336 58,881,208
2020-06-26 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 20 $16.82 $336 58,881,228
2020-06-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 151 $16.84 $2,543 58,881,889
2020-06-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 151 $16.84 $2,543 58,881,738
2020-06-23 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 300 $17.75 $5,325 58,881,411
2020-06-23 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 300 $17.75 $5,325 58,881,711
2020-06-22 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 29 $17.38 $504 58,881,433
2020-06-22 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 29 $17.38 $504 58,881,462
2020-06-19 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 2 $17.95 $36 58,881,467
2020-06-19 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 2 $17.95 $36 58,881,469
2020-06-18 Natauri Jo Dir Open-market sell
S · derivative
6.250% Series A Mandatory Convertible Preferred Stock 630 $59.45 $37,451 96
2020-06-18 Natauri Jo Dir Open-market buy
P · derivative
6.250% Series A Mandatory Convertible Preferred Stock 630 $59.45 $37,451 726
2020-06-18 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 6,798 $17.51 $119,033 58,881,461
2020-06-18 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 6,798 $17.51 $119,033 58,874,663
2020-06-12 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 300 $16.98 $5,094 58,881,101
2020-06-12 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 300 $16.98 $5,094 58,880,801
2020-06-11 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 2,055 $16.92 $34,771 58,880,977
2020-06-11 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 2,055 $16.92 $34,771 58,883,032
2020-05-29 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 35,000 $0.00 $0 88,440
2020-05-29 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 30,000 $0.00 $0 185,160
2020-05-29 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 35,000 $19.07 $667,450 151,671
2020-05-29 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 35,000 $1.60 $56,000 186,671
2020-05-29 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 30,000 $18.57 $557,100 151,671
2020-05-29 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 30,000 $1.60 $48,000 181,671
2020-05-26-04:00 Natauri Jo Open-market sell
S
Common Stock, par value $0.01 per share 13,726,411 $15.90 $218,249,935 58,881,710
2020-05-26 New Mountain Investments III, LLC 10% Open-market sell
S
Common Stock 20,886,424 $15.90 $332,192,308 89,591,565
2020-05-22 Wondrasch Michael EVP & CIO Open-market sell
S
Common Stock 22,987 $17.82 $409,628 154,087
2020-05-20 Brophy Gerard EVP, Biopharma Production Open-market sell
S
Common Stock 25,495 $17.36 $442,593 196,583
2020-05-17 Szlosek Thomas A EVP & CFO Other disposed transaction
F
Common Stock 21,287 $17.86 $380,186 266,134
2020-05-08 SUMME GREGORY L Dir Equity grant / award
A
Common Stock 7,582 $0.00 $0 7,582
2020-04-24 McAllister Eric EVP, CHRO Other disposed transaction
F
Common Stock 8,975 $14.04 $126,009 207,054
2020-04-23 SEVERINO MICHAEL Dir Equity grant / award
A
Common Stock 10,022 $0.00 $0 10,022
2020-03-12 Stubblefield Michael CEO Exercise / conversion
M · derivative
Stock Options (Right to Buy) 200,000 $0.00 $0 1,090,970
2020-03-12 Stubblefield Michael CEO Exercise / conversion
M
Common Stock 200,000 $1.60 $320,000 1,375,635
2020-03-10 GUPTA RAJIV Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 143,000 $0.00 $0 717,645
2020-03-10 GUPTA RAJIV Dir Exercise / conversion
M
Common Stock 143,000 $1.60 $228,800 708,746
2020-02-21 Foxe Tanya EVP, Operations & Supply Chain Equity grant / award
A · derivative
Stock Options (Right to Buy) 66,910 $0.00 $0 66,910
2020-02-21 Foxe Tanya EVP, Operations & Supply Chain Equity grant / award
A
Common Stock 20,751 $0.00 $0 39,458
2020-02-18 Ohri Devashish EVP, IMEA Exercise / conversion
M · derivative
Stock Options (Right to Buy) 20,000 $0.00 $0 123,440
2020-02-18 Ohri Devashish EVP, IMEA Open-market sell
S
Common Stock 20,000 $17.54 $350,800 157,143
2020-02-18 Ohri Devashish EVP, IMEA Exercise / conversion
M
Common Stock 20,000 $1.60 $32,000 177,143
2020-01-21 Henrichwark Sven EVP, APAC Region Equity grant / award
A · derivative
Stock Options (Right to Buy) 140,306 $0.00 $0 140,306
2020-01-21 Henrichwark Sven EVP, APAC Region Equity grant / award
A
Common Stock 14,375 $0.00 $0 14,375
2020-01-13 Murray Mark Christopher EVP, Biomaterials & AT Equity grant / award
A · derivative
Stock Options (Right to Buy) 120,107 $0.00 $0 120,107
2020-01-13 Murray Mark Christopher EVP, Biomaterials & AT Equity grant / award
A
Common Stock 12,376 $0.00 $0 12,376
2020-01-02 Szlosek Thomas A EVP & CFO Equity grant / award
A · derivative
Stock Options (Right to Buy) 222,816 $0.00 $0 222,816
2020-01-02 Szlosek Thomas A EVP & CFO Equity grant / award
A
Common Stock 67,751 $0.00 $0 253,465
2019-09-30 Foxe Tanya EVP, Operations & Supply Chain Equity grant / award
A · derivative
Stock Options (Right to Buy) 171,162 $0.00 $0 171,162
2019-09-30 Foxe Tanya EVP, Operations & Supply Chain Equity grant / award
A
Common Stock 18,707 $0.00 $0 18,707
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 9,922 $14.80 $146,846 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 9,922 $14.80 $146,846 72,630,004
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 5,164 $14.79 $76,376 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 5,164 $14.79 $76,376 72,625,246
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 3,800 $14.78 $56,164 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 3,800 $14.78 $56,164 72,623,882
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 100 $14.79 $1,478 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 100 $14.79 $1,478 72,620,182
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 4,146 $14.76 $61,195 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 4,146 $14.76 $61,195 72,624,228
2019-09-25 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 1,768 $14.70 $25,990 72,620,082
2019-09-25 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 1,768 $14.70 $25,990 72,621,850
2019-09-20 Andres Juan Dir Equity grant / award
A
Common Stock 3,632 $0.00 $0
2019-09-09 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 149,694 $16.46 $2,463,454 72,623,877
2019-09-09 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 149,694 $16.46 $2,463,454 72,773,571
2019-09-06 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 49,200 $17.06 $839,544 72,616,161
2019-09-06 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 49,200 $17.06 $839,544 72,665,361
2019-09-06 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 67,437 $16.51 $1,113,607 72,616,161
2019-09-06 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 67,437 $16.51 $1,113,607 72,683,598
2019-08-12 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 9 $16.66 $150 72,616,449
2019-08-12 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 9 $16.66 $150 72,616,458
2019-08-12 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 16,245 $16.51 $268,259 72,616,449
2019-08-12 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 16,245 $16.51 $268,259 72,632,694
2019-08-06 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 88 $16.66 $1,466 72,614,177
2019-08-06 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 88 $16.66 $1,466 72,614,265
2019-07-31 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 55 $17.55 $965 72,612,175
2019-07-31 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 55 $17.55 $965 72,612,230
2019-06-13-04:00 Natauri Jo Exercise / conversion
X · derivative
Warrants to purchase Common Stock 1,133,920 $0.00 $0 0
2019-06-13-04:00 Natauri Jo Exercise / conversion
X
Common Stock, par value $0.01 per share 1,133,920 $0.00 $2,268 72,605,349
2019-05-21-04:00 Connolly Thomas Equity grant / award
A · derivative
Warrants 1,133,920 1,133,920
2019-05-21-04:00 Connolly Thomas Exercise / conversion
C
Common Stock, par value $0.01 per share 66,471,429 66,471,429
2019-05-21-04:00 Connolly Thomas Equity grant / award
A
Common Stock, par value $0.01 per share 5,000,000 71,471,429
2019-05-17 Natauri Jo Dir Open-market sell
S
Common Stock, par value $0.01 per share 14,049 $14.00 $196,686 67,605,348
2019-05-17 Natauri Jo Dir Open-market buy
P
Common Stock, par value $0.01 per share 13,099 $14.00 $183,386 67,619,397

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
33
Material Event Filings (8-K) — 12 months
15

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.